/ Dr. Kingsley Chin
Kingsley R Chin MD, MBA
Founder, Chairman & Chief Executive Officer
KIC | KIC Ventures
KingsleyChin@KICVentures.com
Executive Leadership
Dr. Kingsley R. Chin leads KIC Ventures, a surgeon led private equity platform focused on spine MedTech, TechMed, and outpatient Interventional Spine Surgery. He directs capital allocation, portfolio strategy, governance, and long term enterprise positioning across majority owned spine companies prepared for global scale.
DR. KINGSLEY R CHIN MD MBA CEO
"Success is built by capital invested into people—and it advances society when reinvested to help others succeed"
-Kingsley R Chin MD MBA
Twenty Year Platform Build
Founded in 2005 around his early spine patents, KIC has completed more than ten strategic mergers and acquisitions. In 2013, KIC Ventures was established as the venture arm to scale spine innovation aligned with the migration toward outpatient care.
Across the portfolio, KIC companies have generated more than 300 million dollars in cumulative revenue. The majority of earnings have been reinvested into research and development, regulatory advancement, intellectual property, manufacturing capability, and infrastructure expansion.
Dr. Chin has personally invested millions of dollars of capital generated through his clinical practice. Over 30 million dollars have been raised from private individual investors without venture capital participation, maintaining surgeon leadership and disciplined ownership.
Harvard Orthopedic Residency: Dr. James H Herndon (left), Dr. Kingsley R Chin (middle) and Dr. Thomas S Thornhill (right)
Innovation and Commercial Track Record
-
Filed over 100 global patents across multiple technology cycles
-
Authored more than 100 peer reviewed scientific publications
-
Brought more than 35 spine products to market
-
Developed and sold the MANTIS platform to Stryker, which generated hundreds of millions in revenue
-
This track record demonstrates translation from concept to commercialization.
Dr. Kingsley R Chin MD MBA
AxioMed and Motion Preservation
In 2014, KIC acquired AxioMed and its viscoelastic disc replacement technology. Dr. Chin oversaw completion of the Lumbar IDE clinical study. AxioMed has obtained regulatory certification in Australia and anticipates FDA approval in 2026, followed by global commercialization in 2027 and 2028.
Planned expansion includes cervical IDE trials, the lateral lumbar disc platform, and smart disc applications integrating motion preservation with advanced data capabilities.
Dr. Kingsley R Chin (left) and Dr. Anthony T Yeung the pioneering inventor of the Yeung endoscopic spine surgery (YESS) system
Late Stage Portfolio Positioned for Scale
Today, the portfolio consists of revenue generating, late stage spine companies supported by:
-
Peer reviewed data
-
Global intellectual property depth
-
Regulatory momentum
-
Vertical manufacturing integration
-
Expanding outpatient adoption
The platform is materially de risked relative to early stage ventures and positioned for multi billion dollar enterprise value potential as regulatory approvals and strategic partnerships align.
Vertical Integration and NANISX Platform
The 2018 acquisition of NanoFuse Biologics established United States based, vertically integrated biologics and disc replacement manufacturing.
Through the NANISX platform, Dr. Chin opened a new niche in Interventional Spine Surgery, training more than 500 interventional pain management physicians to perform sacroiliac joint fusion, lumbar decompression, and lumbar fusion with implants and NanoFuse biologics in ambulatory surgery centers.Procedures once confined to hospital systems are now being safely performed in structured outpatient settings under data driven protocols.
Dr. Kingsley R Chin (left), Dr. Henry Bohlman (middle) and Dr. Augustus White (right)
.jpg)
Dr. Kingsley R Chin and Stryker's Mantis Technology while at NASS
Founder Commitment and Operating Discipline
Dr. Chin remains clinically engaged, performing surgery selectively while dedicating the majority of his time to enterprise leadership. He works daily on regulatory strategy, research protocols, capital planning, product development, and operational execution.
He has trained more than 1000 physicians, serves as adjunct faculty in Jamaica and Professor of Orthopedic Spine Surgery at Florida International University, and has maintained a clinical presence in Kingston, Jamaica for over twenty years.
He is a devoted father of three, an active mentor within the organization, and an avid golfer who values long term relationships with partners and customers.
Dr. Kingsley R. Chin enjoying time with his family.
Dr. Kingsley R. Chin enjoying a round of golf at White Witch Golf Course, Montego Bay, Jamaica, with Dr. Mark Jones
Dr. Chin combines resilience, scientific credibility, disciplined capital reinvestment, vertical integration, and long term strategic control.
He builds infrastructure before scaling.
He protects downside through regulation and evidence.
He positions early for structural shifts.
This is not a speculative venture.
It is a revenue generating, patent deep, vertically integrated, late stage platform built over two decades and prepared for global scale.
Why Institutional Investors Engage
Leadership Books
This book is a potent initiator and energizer. It takes a simplified but holistic approach to success that will motivate and instigate.
Scientific Textbooks
Preface
"Patients deserve the least aggressive care feasible... when this is accomplished, an algorithmic approach can be offered that adequately balances the potential outcomes and known side effects or complications. "
Curtis W. Slipman
2007
Motivational Music
Soundtrack
To our knowledge, this marks the first time a book will be accompanied by a soundtrack... The Prove Yourself Trilogy Album Soundtrack, set to accompany the Prove Yourself book, features three unique albums.
-
Go Get It
-
Fight
-
JamaicHer
